This work is licensed under the Creative Commons Attribution 4.0 International License.
Nankervis H, Thomas KS, Delamere FM i wsp. Scoping systematic review of treatments for eczema. Programme Grants Appl Res. 2016;4(7):1-528.NankervisHThomasKSDelamereFM i wsp.Scoping systematic review of treatments for eczemaProgramme Grants Appl Res201647152810.3310/pgfar0407027280278Search in Google Scholar
Pytkowska K, Głowacka K, Arct J. Lanolina i surowce z niej otrzymywane we współczesnej kosmetologii. Świat Przemysłu Kosmetycznego. 2014;3(19):49-53.PytkowskaKGłowackaKArctJLanolina i surowce z niej otrzymywane we współczesnej kosmetologiiŚwiat Przemysłu Kosmetycznego20143194953Search in Google Scholar
Loden M. The increase in skin hydration after application of emollients with different amounts of lipids. Acta Derm Venereol. 1992;72:327-330.LodenMThe increase in skin hydration after application of emollients with different amounts of lipidsActa Derm Venereol199272327330Search in Google Scholar
van Zuuren EJ, Fedorowicz Z, Christensen R i wsp. Emollients and moisturisers for eczema. Cochrane Database Syst Rev. 2017;2:1-423. CD02119.vanZuuren EJFedorowiczZChristensenR i wsp.Emollients and moisturisers for eczemaCochrane Database Syst Rev201721423CD0211910.1002/14651858.CD012119Search in Google Scholar
Farage MA, Hood W, Odio M i wsp. Skin Surface pH and topical emollient: fact or artifact? JJ Expt Derm Res. 2015;1(4):019-026.FarageMAHoodWOdioM i wsp.Skin Surface pH and topical emollient: fact or artifact?JJ Expt Derm Res201514019026Search in Google Scholar
Hon KL, Kung JSC, Ng WGG, Leung TF. Emollient treatment of atopic dermatitis: latest evidence and clinical considerations. Drugs in Context. 2018;7:212530. Doi: 10.7573/dic.212530.HonKLKungJSCNgWGGLeungTFEmollient treatment of atopic dermatitis: latest evidence and clinical considerationsDrugs in Context2018721253010.7573/dic.212530590826729692852Open DOISearch in Google Scholar
Czarnecka-Operacz M, Sadowska-Przytocka A. Pielęgnacja skóry chorego na AZS w świetle nowoczesnej wiedzy medycznej. Alergia. 2015;3:24-28.Czarnecka-OperaczMSadowska-PrzytockaAPielęgnacja skóry chorego na AZS w świetle nowoczesnej wiedzy medycznejAlergia201532428Search in Google Scholar
Rissman R, Oudshoorn MH, Kocks i wsp. Lanolin-derived lipid mixtures mimic closely the lipid composition and organization of vernix caseosa lipids. Biochim Biophys Acta. 2008;1778(10):2350-2360.RissmanROudshoornMHKocksi wsp.Lanolin-derived lipid mixtures mimic closely the lipid composition and organization of vernix caseosa lipidsBiochim Biophys Acta20081778102350236010.1016/j.bbamem.2008.06.01718655769Search in Google Scholar
Czarnowicki T, Malajian D, Khattri S i wsp. Petrolatum: Barrier repair and antimicrobial responses underlying this „inert” moisturizer. J Allergy Clin Immunol. 2016;137:1091-1102.CzarnowickiTMalajianDKhattriS i wsp.Petrolatum: Barrier repair and antimicrobial responses underlying this „inert” moisturizerJ Allergy Clin Immunol20161371091110210.1016/j.jaci.2015.08.01326431582Search in Google Scholar
Scientific Opinion on the use of high viscosity white mineral oils as a food additive. EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS). EFSA Journal 2009;7(11):1387,1-39.Scientific Opinion on the use of high viscosity white mineral oils as a food additiveEFSA Panel on Food Additives and Nutrient Sources added to Food (ANS)EFSA Journal2009711138713910.2903/j.efsa.2009.1387Search in Google Scholar
Garty BZ. High plasma urea concentration in babies with lamellar ichtyosis. Arch Dis Child. 1986;61:696-698.GartyBZHigh plasma urea concentration in babies with lamellar ichtyosisArch Dis Child19866169669810.1136/adc.61.7.69617778833740911Search in Google Scholar
Werfel T, Heratizadeh A, Aberer W i wsp. S2k guideline on diagnosis and treatment of atopic dermatitis – short version. Allergo J Int. 2016;25:82-95.WerfelTHeratizadehAAbererW i wsp.S2k guideline on diagnosis and treatment of atopic dermatitis – short versionAllergo J Int201625829510.1007/s40629-016-0110-8486174227239428Search in Google Scholar
Kerschner M, Williams S. Skin care in atopic eczema. [w]: Ring J., Przybilla B., Ruzicka T. (red): Handbook of Atopic Eczema. Springer Berlin, Heidelberg, 2006; 524-533.KerschnerMWilliamsSSkin care in atopic eczema. [w]RingJ.PrzybillaB.RuzickaT.redHandbook of Atopic EczemaSpringer Berlin, Heidelberg200652453310.1007/3-540-29856-8_56Search in Google Scholar
Wollenberg A, Oranje A, Deleuran M i wsp. ETFAD/EADV Eczema task force 2015 position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients. JEADV 2016;30:729-747.WollenbergAOranjeADeleuranM i wspETFAD/EADV Eczema task force2015position paper on diagnosis and treatment of atopic dermatitis in adult and paediatric patients. JEADV 20163072974710.1111/jdv.1359927004560Search in Google Scholar
Manuschiatti W, Maibach HI. Hyaluronic acid and skin: wound healing and aging. Int J Dermatol. 1996;35(8):539-544.ManuschiattiWMaibachHIHyaluronic acid and skin: wound healing and agingInt J Dermatol199635853954410.1111/j.1365-4362.1996.tb03650.x8854147Search in Google Scholar
Cosmetic Ingredient Review Expert Panel Report. Safety assessment of panthenol, panthotenic acid, and derivatives as used in cosmetics. CIR. 2017, Washington, 1-52.Cosmetic Ingredient Review Expert Panel Report. Safety assessment of panthenol, panthotenic acid, and derivatives as used in cosmetics. CIR2017Washington152Search in Google Scholar
Hoare C, Li Wan Po A, Williams H. Systematic review of treatments for atopic eczema. Health Technol Assess 2000;4 (37):1-8.HoareCLiWan Po AWilliamsH.Systematic review of treatments for atopic eczemaHealth Technol Assess20004371810.3310/hta4370Search in Google Scholar
Palmer CN, Irvine AD, Terron-Kwiatkowski A i wsp. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet. 2006;38:441-446.PalmerCNIrvineADTerron-KwiatkowskiA i wsp.Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitisNat Genet20063844144610.1038/ng176716550169Search in Google Scholar
Elias PM. Lipid abnormalities and lipid-based repair strategies in atopic dermatitis. Biochim Biophys Acta. 2014;1841(3):323-330.EliasPMLipid abnormalities and lipid-based repair strategies in atopic dermatitisBiochim Biophys Acta20141841332333010.1016/j.bbalip.2013.10.001394349124128970Search in Google Scholar
Kezic S, Kemperman PM, Koster ES i wsp. Loss-of-function mutations in the filaggrin gene lead to reduced level of natural moisturizing factor in the stratum corneum. J Invest Dermatol 2008;128:2117-2119.KezicSKempermanPMKosterES i wsp.Loss-of-function mutations in the filaggrin gene lead to reduced level of natural moisturizing factor in the stratum corneumJ Invest Dermatol20081282117211910.1038/jid.2008.2918305568Search in Google Scholar
Kim BE, Leung DYM. Significance of skin barrier dysfunction in atopic dermatitis. Allergy Asthma Immunol Res. 2018;10(3):207-215.KimBELeungDYMSignificance of skin barrier dysfunction in atopic dermatitisAllergy Asthma Immunol Res201810320721510.4168/aair.2018.10.3.207591143929676067Search in Google Scholar
Kennedy EA, Connolly J, Hourihane JO`B i wsp. Skin microbiome before development of atopic dermatitis: early colonization with commensal staphylococci at 2 months is associated with a lower risk of atopic dermatitis at 1 year. J Allergy Clin Immunol. 2017;139:166-172.KennedyEAConnollyJHourihaneJO`B i wsp.Skin microbiome before development of atopic dermatitis: early colonization with commensal staphylococci at 2 months is associated with a lower risk of atopic dermatitis at 1 yearJ Allergy Clin Immunol201713916617210.1016/j.jaci.2016.07.029520779627609659Search in Google Scholar
Petry V, Lipnharski C, Bessa GR, Silveira VB, Weber MB. Prevalence of community-acquired methicillin-resistant Staphylococcus aureus and antibiotic resistance in patients with atopic dermatitis in Porto Alegre, Brazil. Intern J Dermatol. 2013;53(6):731-735.PetryVLipnharskiCBessaGRSilveiraVBWeberMBPrevalence of community-acquired methicillin-resistant Staphylococcus aureus and antibiotic resistance in patients with atopic dermatitis in Porto Alegre, BrazilIntern J Dermatol201353673173510.1111/ijd.1202024168078Search in Google Scholar
Meylan P, Lang C, Mermoud S i wsp. Skin colonization by Staphylococcus aureus precedes the clinical diagnosis of atopic dermatitis in infancy. J Invest Dermatol. 2017;137(12):2497-2504.MeylanPLangCMermoudS i wsp.Skin colonization by Staphylococcus aureus precedes the clinical diagnosis of atopic dermatitis in infancyJ Invest Dermatol2017137122497250410.1016/j.jid.2017.07.83428842320Search in Google Scholar
Berardesca E, Barbareschi M, Veraldi S, Pimpinelli N. Evaluation of efficacy of a skin lipid mixture in patients with irritant contact dermatitis, allergic contact dermatitis or atopic dermatitis: a multicenter study. Contact Dermatitis 2001;45:280–285. http://dx.doi.org/10.1034/j.1600-05362001.450505.x.BerardescaEBarbareschiMVeraldiSPimpinelliNEvaluation of efficacy of a skin lipid mixture in patients with irritant contact dermatitis, allergic contact dermatitis or atopic dermatitis: a multicenter studyContact Dermatitis200145280285http://dx.doi.org/10.1034/j.1600-05362001.450505.x10.1034/j.1600-0536.2001.450505.x11722487Search in Google Scholar
Loden M, Andersson AC, Andersson C i wsp. Instrumental and dermatologist evaluation of the effect of glycerine and urea on dry skin in atopic dermatitis. Skin Res Technol 2001;7:209-213. doi.org/10.1034/j.1600-0846.2001.070401.x.LodenMAnderssonACAnderssonC i wsp.Instrumental and dermatologist evaluation of the effect of glycerine and urea on dry skin in atopic dermatitisSkin Res Technol20017209213doi.org/10.1034/j.1600-0846.2001.070401.xOpen DOISearch in Google Scholar
Loden M, Andersson AC, Anderson C i wsp. A double-blind study comparing the effect of glycerin and urea on dry, eczematous skin in atopic patients. Acta Derm Venereol 2002;82:45-47. doi.org/10.1080/000155502753600885.LodenMAnderssonACAndersonC i wsp.A double-blind study comparing the effect of glycerin and urea on dry, eczematous skin in atopic patientsActa Derm Venereol2002824547doi.org/10.1080/000155502753600885Open DOISearch in Google Scholar
Amichai B, Grunwald MH. A randomized, double-blind, placebo-controlled study to evaluate the efficacy in AD of liquid soap containing 12% ammonium lactate + 20% urea. Clin Exp Dermatol 2009;34:e602-604. doi.org/10.1111/j.1365-2230.2009.03273.x.AmichaiBGrunwaldMHA randomized, double-blind, placebo-controlled study to evaluate the efficacy in AD of liquid soap containing 12% ammonium lactate + 20% ureaClin Exp Dermatol200934e602604doi.org/10.1111/j.1365-2230.2009.03273.xOpen DOISearch in Google Scholar
Sugarman JL, Parish LC. Efficacy of a lipid-based barrier repair formulation in moderate-to- severe pediatric atopic dermatitis. J Drugs Dermatol 2009;8:1106-1111.SugarmanJLParishLCEfficacy of a lipid-based barrier repair formulation in moderate-to- severe pediatric atopic dermatitisJ Drugs Dermatol2009811061111Search in Google Scholar
Bissonette R, Maari C, Provost N i wsp. A double-blind study of tolerance and efficacy of a new urea-containing moisturizer in patients with atopic dermatitis. J Cosmet Dermatol 2010; 9:16-21. 10.1111/j.1473-2165.2010.00476.x.BissonetteRMaariCProvostN i wsp.A double-blind study of tolerance and efficacy of a new urea-containing moisturizer in patients with atopic dermatitisJ Cosmet Dermatol20109162110.1111/j.1473-2165.2010.00476.x20367668Open DOISearch in Google Scholar
Draelos ZD. A clinical evaluation of the comparable efficacy of hyaluronic acid-based foam and ceramide-containing emulsion cream in the treatment of mild-to-moderate atopic dermatitis. J Cosmet Dermatol. 2011;10:185-188. doi.org/10.1111/j.1473-2165.2011.00568.x.DraelosZDA clinical evaluation of the comparable efficacy of hyaluronic acid-based foam and ceramide-containing emulsion cream in the treatment of mild-to-moderate atopic dermatitisJ Cosmet Dermatol201110185188doi.org/10.1111/j.1473-2165.2011.00568.xOpen DOISearch in Google Scholar
Wiren K, Nohlgard C, Nyberg F i wsp. Treatment with a barrier-strengthening moisturizing cream delays relapse of atopic dermatitis: a prospective and randomized controlled clinical trial. JEADV 2009;23:1267-1272.WirenKNohlgardCNybergF i wsp.Treatment with a barrier-strengthening moisturizing cream delays relapse of atopic dermatitis: a prospective and randomized controlled clinical trialJEADV2009231267127210.1111/j.1468-3083.2009.03303.x19508310Search in Google Scholar
Lucky AW, Leach AD, Laskarzewski P i wsp. Use of an emollient as a steroid-sparing agent in the treatment of mild to moderate atopic dermatitis in children. Pediatr Dermatol. 1997;14:321-324.LuckyAWLeachADLaskarzewskiP i wsp.Use of an emollient as a steroid-sparing agent in the treatment of mild to moderate atopic dermatitis in childrenPediatr Dermatol19971432132410.1111/j.1525-1470.1997.tb00968.x9263319Search in Google Scholar
Loden M, Andersson AC, Lindberg M. Improvement in skin barrier function in patients with atopic dermatitis after treatment with a moisturizing cream (Canoderm). Br J Dermatol 1999; 140: 264-267.LodenMAnderssonACLindbergMImprovement in skin barrier function in patients with atopic dermatitis after treatment with a moisturizing cream (Canoderm)Br J Dermatol199914026426710.1046/j.1365-2133.1999.02660.x10233220Search in Google Scholar
Grimalt R, Mengeaud V, Cambazard F, Study Investigators Group. The steroid-sparing effect of an emollient therapy in infants with atopic dermatitis: a randomized controlled study. Dermatology 2007; 214: 61-67. doi.org/10.1159/000096915GrimaltRMengeaudVCambazardFStudyInvestigators Group.The steroid-sparing effect of an emollient therapy in infants with atopic dermatitis: a randomized controlled studyDermatology20072146167doi.org/10.1159/000096915Open DOISearch in Google Scholar
Msika P, De Belilovsky C, Piccardi N i wsp. New emollient with topical corticosteroid-sparing effect in treatment of childhood atopic dermatitis: SCORAD and quality of life improvement. Pediatr Dermatol. 2008;25:606-612. doi.org/10.1111/j.1525-1470.2008.00783.x.MsikaPDeBelilovsky CPiccardiN i wsp.New emollient with topical corticosteroid-sparing effect in treatment of childhood atopic dermatitis: SCORAD and quality of life improvementPediatr Dermatol200825606612doi.org/10.1111/j.1525-1470.2008.00783.xOpen DOISearch in Google Scholar
De Belilovsky C, Roo-Rodriguez E, Baudouin C i wsp. Natural peroxisome proliferator-activated receptor-alpha agonist cream demonstrates similar therapeutic response to topical steroids in atopic dermatitis. J Dermatolog Treat. 2011;22:359-365. doi.org/10.3109/09546634.2010.499932.DeBelilovsky CRoo-RodriguezEBaudouinC i wsp.Natural peroxisome proliferator-activated receptor-alpha agonist cream demonstrates similar therapeutic response to topical steroids in atopic dermatitisJ Dermatolog Treat201122359365doi.org/10.3109/09546634.2010.499932Open DOISearch in Google Scholar
Simpson E, Dutronc Y. A new body moisturizer increases skin hydration and improves atopic dermatitis symptoms among children and adults. J Drugs Dermatol. 2011;10:744-749.SimpsonEDutroncYA new body moisturizer increases skin hydration and improves atopic dermatitis symptoms among children and adultsJ Drugs Dermatol201110744749Search in Google Scholar
Glatz M, Jo JH, Kennedy EA i wsp. Emollient use alters skin barrier and microbes in infants at risk for developing atopic dermatitis. Plos One. 2018;13(2):e0192443.GlatzMJoJHKennedyEA i wsp.Emollient use alters skin barrier and microbes in infants at risk for developing atopic dermatitisPlos One2018132e019244310.1371/journal.pone.0192443583029829489859Search in Google Scholar
Simpson EL, Chalmers JR, Hanifin JM i wsp. Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention. J Allergy Clin Immunol. 2014;134:818-823.SimpsonELChalmersJRHanifinJM i wsp.Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis preventionJ Allergy Clin Immunol201413481882310.1016/j.jaci.2014.08.005418000725282563Search in Google Scholar
Horimukai K, Morita K, Narita M i wsp. Application of moisturizer to neonates prevents development of atopic dermatitis. J Allergy Clin Immunol. 2014;134:824-830.e6.HorimukaiKMoritaKNaritaM i wsp.Application of moisturizer to neonates prevents development of atopic dermatitisJ Allergy Clin Immunol2014134824830e610.1016/j.jaci.2014.07.06025282564Search in Google Scholar
Darmstadt GL, Ahmed S, Ahmed AS, Saha SK. Mechanism for prevention of infection in preterm neonates by topical emollients: a randomized, controlled clinical trial. Pediatr Infect Dis J. 2014;33(11):1124-1127.DarmstadtGLAhmedSAhmedASSahaSKMechanism for prevention of infection in preterm neonates by topical emollients: a randomized, controlled clinical trialPediatr Infect Dis J201433111124112710.1097/INF.000000000000042324853544Search in Google Scholar
Belloni G, Pinelli S, Veraldi S. A randomized, double-blind, vehicle-controlled study to evaluate the efficacy and safety of MAS063DP (Atopiclar) in the treatment of mild to moderate atopic dermatitis. Eur J Dermatol 2005;15:31-36.BelloniGPinelliSVeraldiSA randomized, double-blind, vehicle-controlled study to evaluate the efficacy and safety of MAS063DP (Atopiclar) in the treatment of mild to moderate atopic dermatitisEur J Dermatol2005153136Search in Google Scholar
Abramovits W, Boguniewicz M for the Adult Atopiclar Study Group. A multicenter, randomized, vehicle-controlled clinical study to examine the efficacy and safety of MAS063DP (Atopiclar) in the management of mild to moderate atopic dermatitis in adults. J Drugs Dermatol. 2006;5:236-244.AbramovitsWBoguniewiczM for the Adult Atopiclar Study Group.A multicenter, randomized, vehicle-controlled clinical study to examine the efficacy and safety of MAS063DP (Atopiclar) in the management of mild to moderate atopic dermatitis in adultsJ Drugs Dermatol20065236244Search in Google Scholar
Boguniewicz M, Zeichner JA, Eichenfield LF i wsp. MAS063DP is effective monotherapy for mild to moderate atopic dermatitis in infants and children: a multicenter, randomized, vehicle-controlled study. J Pediatr 2008;152:854-859.BoguniewiczMZeichnerJAEichenfieldLF i wsp.MAS063DP is effective monotherapy for mild to moderate atopic dermatitis in infants and children: a multicenter, randomized, vehicle-controlled studyJ Pediatr200815285485910.1016/j.jpeds.2007.11.03118492531Search in Google Scholar
Patrizi A, Capitanio B, Neri I i wsp. A double-blind, randomized, vehicle-controlled clinical study to evaluate the efficacy and safety of MAS063DP (Atopiclar) in the management of atopic dermatitis in paediatric patients. Pediatr Allergy Immunol. 2008;19:619-625.PatriziACapitanioBNeriI i wsp.A double-blind, randomized, vehicle-controlled clinical study to evaluate the efficacy and safety of MAS063DP (Atopiclar) in the management of atopic dermatitis in paediatric patientsPediatr Allergy Immunol200819619625Search in Google Scholar
Miller DW, Koch SB, Yentzer BA i wsp. An over-the-counter moisturizer is a clinically effective as, and more cost-effective than, prescription barrier creams in the treatment of children with mild-to-moderate atopic dermatitis: a randomized, controlled trial. J Drugs Dermatol. 2011;10:531-537.MillerDWKochSBYentzerBA i wsp.An over-the-counter moisturizer is a clinically effective as, and more cost-effective than, prescription barrier creams in the treatment of children with mild-to-moderate atopic dermatitis: a randomized, controlled trialJ Drugs Dermatol201110531537Search in Google Scholar
Eichenfield LE, Ahluwalia J, Waldman A i wsp. Current guidelines for the evaluation and management of atopic dermatitis: A comparison of the Joint Task Force Practice Parameter and American Academy of Dermatology Guidelines. J Allergy Clin Immunol. 2017;139(4S):S49-S57. 10.1016/j.jaci.2017.01.009.EichenfieldLEAhluwaliaJWaldmanA i wsp.Current guidelines for the evaluation and management of atopic dermatitis: A comparison of the Joint Task Force Practice Parameter and American Academy of Dermatology GuidelinesJ Allergy Clin Immunol20171394SS49S5710.1016/j.jaci.2017.01.00910.1016/j.jaci.2017.01.00928390477Search in Google Scholar
Scottish Intercollegiate Guidelines Network (SIGN. Management of atopic eczema in primary care. SIGN publication no. 125. Edinburgh, SIGN, 2011.Scottish Intercollegiate Guidelines Network (SIGN. Management of atopic eczema in primary care. SIGN publication no. 125Edinburgh, SIGN2011Search in Google Scholar
